Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
作者： Bruce D. Behounek , Mark E. McGovern , Adeoye Y. Olukotun
DOI:
关键词:
摘要: A method is provided for preventing or reducing the risk of onset a cardiovascular event by administering an HMG CoA reductase inhibitor such as pravastatin, to patient which has one more factors coronary and/or cerebrovascular hypercholesterolemia.
google.co.in 参考文章(19)
Joseph L. Goldstein, Michael S. Brown, The LDL receptor defect in familial hypercholesterolemia. Implications for pathogenesis and therapy. Medical Clinics of North America. ,vol. 66, pp. 335- 362 ,(1982) , 10.1016/S0025-7125(16)31424-9
T Funahashi, T Yamamura, A Kawaguchi, A Yamamoto, K Ishikawa, S Beppu, T Kamiya, Y Horiguchi, S Yokoyama, Y Miyake, Clinical features of familial hypercholesterolemia Arteriosclerosis (Dallas, Tex.). ,vol. 9, ,(1989)
Gary James Grover, James Laverne Bergey, Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation ,(1989)
John C. Alexander, Adeoye Y. Olukotun, Method for preventing a second heart attack employing an HMG CoA reductase inhibitor ,(1991)
Bernward Dr. Schölkens, Use of angiotensin-converting enzyme inhibitors in the treatment of atherosclerosis, thrombosis and peripheral vascular disease ,(1986)
B. LEWIS, On lowering lipids in the post-infarction patient Journal of Internal Medicine. ,vol. 229, pp. 483- 488 ,(1991) , 10.1111/J.1365-2796.1991.TB00381.X
G. Schettler, The role of diet and drugs in lowering serum cholesterol in the postmyocardial infarction patient. Cardiovascular Drugs and Therapy. ,vol. 2, pp. 795- 799 ,(1989) , 10.1007/BF00133210
Thomas A. Pearson, Herbert J. Marx, The rapid reduction in cardiac events with lipid-lowering therapy: Mechanisms and implications The American Journal of Cardiology. ,vol. 72, pp. 1072- 1073 ,(1993) , 10.1016/0002-9149(93)90864-9
Lars Wilhelmsen, Practical guidelines for drug therapy after myocardial infarction. Drugs. ,vol. 38, pp. 1000- 1007 ,(1989) , 10.2165/00003495-198938060-00010
J.R. Crouse, R.P. Byington, M.G. Bond, M.A. Espeland, J.W. Sprinkle, M. McGovern, C.D. Furberg, Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome. Controlled Clinical Trials. ,vol. 13, pp. 495- 506 ,(1992) , 10.1016/0197-2456(92)90206-F